In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
As of close of business last night, Verrica Pharmaceuticals Inc’s stock clocked out at $0.61, down -1.34% from its previous closing price of $0.62. In other words, the price has decreased by -$1.34 from its previous closing price. On the day, 0.11 million shares were traded. VRCA stock price reached its highest trading level at $0.6376 during the session, while it also had its lowest trading level at $0.6022.
Ratios:
To gain a deeper understanding of VRCA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.26 and its Current Ratio is at 1.34.
Needham Upgraded its Hold to Buy on July 25, 2023, while the target price for the stock was maintained at $10.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 17 ’25 when Hayes Christopher G. sold 4,315 shares for $0.65 per share. The transaction valued at 2,805 led to the insider holds 176,458 shares of the business.
Hayes Christopher G. sold 26,183 shares of VRCA for $69,647 on Aug 26 ’24. The CHIEF LEGAL OFFICER now owns 115,303 shares after completing the transaction at $2.66 per share. On Aug 27 ’24, another insider, Hayes Christopher G., who serves as the CHIEF LEGAL OFFICER of the company, sold 9,530 shares for $2.46 each. As a result, the insider received 23,444 and left with 105,773 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VRCA now has a Market Capitalization of 56576744 and an Enterprise Value of 69414744. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.88. Its current Enterprise Value per Revenue stands at 9.669 whereas that against EBITDA is -1.292.
Stock Price History:
The Beta on a monthly basis for VRCA is 1.84, which has changed by -0.9273159 over the last 52 weeks, in comparison to a change of 0.09362543 over the same period for the S&P500. Over the past 52 weeks, VRCA has reached a high of $9.36, while it has fallen to a 52-week low of $0.38. The 50-Day Moving Average of the stock is 18.97%, while the 200-Day Moving Average is calculated to be -46.08%.
Shares Statistics:
It appears that VRCA traded 403.55K shares on average per day over the past three months and 277580 shares per day over the past ten days. A total of 91.79M shares are outstanding, with a floating share count of 50.08M. Insiders hold about 45.85% of the company’s shares, while institutions hold 31.92% stake in the company. Shares short for VRCA as of 1745971200 were 2705936 with a Short Ratio of 6.71, compared to 1743379200 on 2845850. Therefore, it implies a Short% of Shares Outstanding of 2705936 and a Short% of Float of 5.2699998.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
